Prospective Cohort Study of Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma in 8510 Patients
2006 · Gastroenterology · 809 citations
https://doi.org/10.1053/j.gastro.2006.05.021
K
Kiwamu Okita
Tokuyama (Japan)(JP)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
439
Papers
17.6K
Citations
67
h-index
218
i10-index
Kiwamu Okita is an academic researcher from Tokuyama (Japan). The author has contributed to research in topics: Liver Disease Diagnosis and Treatment & Hepatocellular Carcinoma Treatment and Prognosis & Hepatitis C virus research. The author has an h-index of 67, co-authored 374 publications.
Papers by this author
worksREFLECT—a phase 3 trial comparing efficacy and safety of lenvatinib to sorafenib for the treatment of unresectable hepatocellular carcinoma: an analysis of Japanese subset
2019 · Journal of Gastroenterology · 217 citations
https://doi.org/10.1007/s00535-019-01642-1
Survey of survival among patients with hepatitis C virus-related hepatocellular carcinoma treated with peretinoin, an acyclic retinoid, after the completion of a randomized, placebo-controlled trial
2014 · Journal of Gastroenterology · 39 citations
https://doi.org/10.1007/s00535-014-0996-1
Can serum albumin level affect the pharmacological action of tolvaptan in patients with liver cirrhosis? A post hoc analysis of previous clinical trials in Japan
2015 · Journal of Gastroenterology · 33 citations
https://doi.org/10.1007/s00535-015-1052-5
Giant cavernous hepatic hemangioma shrunk by use of sorafenib
2012 · Clinical Journal of Gastroenterology · 30 citations
https://doi.org/10.1007/s12328-012-0343-0
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat